AMSPC and ASPET began a collaborative webinar series this year called “Future Leaders in Pharmacology” that gives visibility to early career scientists—nominated by department chairs or ASPET division chairs—who show promise as future leaders in the field, an important aide to young scientists entering a crowded job market during a uncertain time for science. But, like ASPET and other leading associations within their fields, AMSPC has been resilient during this turbulent period and provided support for members and students through its annual conference, advocacy, and continued focus on advancing scientific knowledge.
It is a challenging time for international scientists who want to visit the USA. Wait times for visas have increased dramatically since 2024. Many visa requests by scientists are denied for unexplained reasons. And international scientists who do manage to make it to the USA for a meeting are sometimes detained and grilled by immigration officials.
Executive Officer Dave Jackson discusses programming highlights at ASPET’s upcoming Annual Meeting, including the daily Keynote speakers, the diverse selection of sessions touching on all areas of pharmacology, the 500+ posters, the GPCR Colloquium, the variety of networking and community-building opportunities, and more.
Prostate cancer is one of the most commonly occurring cancers in the United States and remains the second-leading cause of death among men. The American Cancer Society predicts that prostate cancer will claim more than 35,000 American lives this year.1 Advanced cases of the disease are difficult to manage because patients become increasingly unresponsive to treatment and succumb to severe side effects.
A Conversation with Aiming Yu, PhD
ASPET Welcomes New Members
Honoring ASPET members who have passed.
The creation of the ASPET Road Show is one of the many avenues ASPET has taken to help support our scientists and further engage them in science advocacy.
In Industry Insights, members of ASPET’s Industry Science Committee discuss the intersection of pharmacology and industry, private sector highlights, and how the industry and membership can support each other.
A showcase of early-career scientists—what drives them and why pharmacology is important to them.
